These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pancytopenia related eosinophilia in rheumatoid arthritis: a specific methotrexate phenomenon? Bruyn GA; Velthuysen E; Joosten P; Houtman PM J Rheumatol; 1995 Jul; 22(7):1373-6. PubMed ID: 7562775 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis]. Gubar' EE; Bochkova AG; Bunchuk NV Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110 [TBL] [Abstract][Full Text] [Related]
7. [The treatment of rheumatoid arthritis with low dose pulse methotrexate--comparative study with other disease modifying antirheumatic drugs]. Murayama T; Ubukata A; Nakazaki S Ryumachi; 1992 Feb; 32(1):3-11. PubMed ID: 1604414 [TBL] [Abstract][Full Text] [Related]
8. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone. Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189 [TBL] [Abstract][Full Text] [Related]
10. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years. Lim AY; Gaffney K; Scott DG Rheumatology (Oxford); 2005 Aug; 44(8):1051-5. PubMed ID: 15901903 [TBL] [Abstract][Full Text] [Related]
11. [Therapeutic maintenance level of methotrexate in rheumatoid arthritis]. Tahiri L; Allali F; Jroundi I; Abouqal R; Hajjaj-Hassouni N Sante; 2006; 16(3):167-72. PubMed ID: 17284392 [TBL] [Abstract][Full Text] [Related]
12. Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate. Carroll GJ; Thomas R; Phatouros CC; Atchison MH; Leslie AL; Cook NJ; D'Souza I J Rheumatol; 1994 Jan; 21(1):51-4. PubMed ID: 8151587 [TBL] [Abstract][Full Text] [Related]
13. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies. Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612 [TBL] [Abstract][Full Text] [Related]
17. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment. Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853 [TBL] [Abstract][Full Text] [Related]
18. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy. van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ; Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331 [TBL] [Abstract][Full Text] [Related]
19. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment. Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504 [TBL] [Abstract][Full Text] [Related]
20. Pancytopenia and severe cytopenia induced by low-dose methotrexate. Eight case-reports and a review of one hundred cases from the literature (with twenty-four deaths). Berthelot JM; Maugars Y; Hamidou M; Chiffoleau A; Barrier J; Grolleau JY; Prost A Rev Rhum Engl Ed; 1995; 62(7-8):477-86. PubMed ID: 8574610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]